chr7-100057380-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_145914.3(ZSCAN21):c.374G>A(p.Arg125Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000511 in 1,565,254 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_145914.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZSCAN21 | NM_145914.3 | c.374G>A | p.Arg125Gln | missense_variant | 2/4 | ENST00000292450.9 | NP_666019.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZSCAN21 | ENST00000292450.9 | c.374G>A | p.Arg125Gln | missense_variant | 2/4 | 1 | NM_145914.3 | ENSP00000292450.4 | ||
ZSCAN21 | ENST00000456748.6 | c.374G>A | p.Arg125Gln | missense_variant | 2/5 | 5 | ENSP00000390960.2 | |||
ZSCAN21 | ENST00000438937.1 | c.374G>A | p.Arg125Gln | missense_variant | 3/4 | 2 | ENSP00000404207.1 | |||
ZSCAN21 | ENST00000477297.1 | n.470G>A | non_coding_transcript_exon_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000297 AC: 6AN: 202230Hom.: 0 AF XY: 0.0000276 AC XY: 3AN XY: 108618
GnomAD4 exome AF: 0.0000517 AC: 73AN: 1412900Hom.: 0 Cov.: 31 AF XY: 0.0000487 AC XY: 34AN XY: 698508
GnomAD4 genome AF: 0.0000459 AC: 7AN: 152354Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74512
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at